openPR Logo
Press release

The Atrophic Scar Treatment Market To Thrive Backed By Wearable Technology

08-26-2022 10:46 AM CET | Health & Medicine

Press release from: Persistence Market Research

The Atrophic Scar Treatment Market To Thrive Backed By Wearable

According to a recently conducted research by Persistence Market Research titled "Atrophic Scar Treatment Market: Global Industry Analysis 2012 - 2016 and Forecast 2017 - 2025," the global atrophic scar treatment market is expected to witness moderate growth during an eight-year forecast period 2017-2025. Over the assessment period, the market is likely to thrive at a CAGR of 4.6%. In 2017, global sales of atrophic scar treatments registered revenue worth a value of US$ 4.65 Bn in 2017, which is anticipated to reach beyond US$ 6.5 Bn by the end of 2025.

"Popularity of lasers and injectables will surge over the years, compared to other product types such as topical scar products and surface treatment. Although topical scar products will retain dominance during 2017-2025 with more than 50% market value share, a gradual decline can be observed with time.

Get Going With Sample Of Atrophic Scar Treatment Market Report! https://www.persistencemarketresearch.com/samples/22468

Company Profiles

Merz Inc.
Enaltus LLC
Oculus Innovative Sciences Inc.
CCA Industries Inc.
Cynosure Inc.
LUMENIS
Syneron Medical Ltd.
NutraMarks Inc.
Mölnlycke Health Care
Pacific World Corporation
Valeant Pharmaceuticals International Inc
Shanghai Fosun Pharmaceuticals Ltd(ACAlma Lasers)
Beijing Toplaser Technology Co. Ltd
Sonoma Pharmaceuticals Inc.

How About Re-Inventing The Methodical Wheel In The Atrophic Scar Treatment Market? Switch Over To The "Methodology" Tab! https://www.persistencemarketresearch.com/methodology/22468

While laser therapy is foreseen to emerge popular among wealthy consumers, injectable products will also witness a positive market outlook. Higher treatment costs will persist as a major adoption challenge though", reports a healthcare market research analyst at Persistence Market Research.

When it comes to end-user analysis, hospitals are expected to remain dominant with over 35% market value share in 2025. Clinics and pharmacies and drug stores are anticipated to witness stable growth, whereas E-Commerce is likely to emerge popular owing to increasingly growing adoption of online technologies by consumers worldwide.

In addition to growing demand for atrophic scar treatment, the market will experience a major thrust from the changing regulatory landscape in both developed and developing countries. Growing prevalence of skin disorders, increasing demand for sophisticated treatments, persistent product innovations, higher preference for personal care, and surging demand for age-defying treatments are also identified to predominantly fuel revenue growth of the global atrophic scar treatment market.

The regional assessment of global atrophic scar treatment market indicates continued dominance of the North America regional market, followed by Asia Pacific and Europe. By the end of 2025, the North America market for atrophic scar treatment is foreseen to exceed a value of US$ 2.6 Bn. APAC will be led by China, India, and Japan, whereas the Latin America market will be spearheaded by Brazil. Latin America is expected to emerge as the fastest growing regional market for atrophic scar treatment in the coming years.

Keeping A Tab On Key Players In The Atrophic Scar Treatment Market? Go To "Purchase Now" To Decipher The Competitive Analysis In Our Atrophic Scar Treatment Market Report! https://www.persistencemarketresearch.com/checkout/22468

Key Players to Focus on Direct Feedback Analysis to Incorporate "Voice of Customer"

Among the key players operating in the global landscape of atrophic scar treatment, maximum companies are identified to concentrate more on the direct feedback analysis strategy in a bid to incorporate the "voice of customer". Others are focusing on enhancing their core competencies and gaining an expanded market share by launching new products in the marketplace.

Some of the leading companies include Smith & Nephew Inc., Merz inc., CCA Industries Inc., Avita Medical Limited, Occulus Innovative Sciences, Inc., Pacific World Corp., Valeant Inc., Enaltus LLC, Molnlycke Health Care, Cynosure, Inc., Sonoma Pharmaceuticals, Inc., Shanghai Fosun Pharmaceuticals (Alma Lasers), and LUMENIS.

Key insights

The global market value for atrophic scar treatment is expected to register 1.3x growth during 2017-2025

Topical scar treatment products may lose popularity gradually, owing to growing consumer preference for laser therapies and injectable products

North America's dominance is expected to prevail; however, Latin America will witness the fastest growth

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Atrophic Scar Treatment Market To Thrive Backed By Wearable Technology here

News-ID: 2717316 • Views:

More Releases from Persistence Market Research

HIV AIDS Testing Market Sales Estimated to Hit USD 6.6 Billion by 2032| Says Persistence Market Research
HIV AIDS Testing Market Sales Estimated to Hit USD 6.6 Billion by 2032| Says Per …
Introduction The HIV AIDS testing market has gained significant importance in recent years due to the global focus on early diagnosis, prevention, and management of HIV infections. Timely and accurate testing plays a crucial role in reducing transmission rates, improving patient outcomes, and supporting public health initiatives worldwide. With advancements in diagnostics, including rapid tests, ELISA, and molecular assays, HIV testing has become more accessible, reliable, and efficient across healthcare settings. For
Urinary Catheters Market to Surge at 5.6% CAGR, Hitting US$ 3.1 Bn by 2032, According to PMR Study
Urinary Catheters Market to Surge at 5.6% CAGR, Hitting US$ 3.1 Bn by 2032, Acco …
Introduction The urinary catheters market has witnessed significant growth in recent years, driven by its essential role in managing urinary retention, incontinence, surgical interventions, and other urological disorders. Urinary catheters are widely used across hospitals, long-term care facilities, and home healthcare settings due to their effectiveness in draining urine from the bladder and supporting patients with chronic or temporary urinary complications. Known for their clinical importance, adaptability, and availability in various
3D Bioprinting Market Size is Expected to Reach 7.39 Billion by 2032, Rising at a Market Growth of 15% CAGR During the Forecast Period
3D Bioprinting Market Size is Expected to Reach 7.39 Billion by 2032, Rising at …
Introduction The 3D bioprinting market has gained significant momentum in recent years due to its transformative potential in healthcare, pharmaceutical research, and regenerative medicine. Known for its ability to precisely fabricate complex biological structures, 3D bioprinting is widely applied in areas such as tissue engineering, organ regeneration, drug testing, and personalized medicine. By enabling the creation of living tissues with high accuracy, this technology is revolutionizing research capabilities and paving the
Viral Molecular Diagnostic Market to Grow at a CAGR of 9.0% from 2025 to 2032, reaching US$ 7.3 Bn as per PMR Study
Viral Molecular Diagnostic Market to Grow at a CAGR of 9.0% from 2025 to 2032, r …
Introduction The viral molecular diagnostic market has gained substantial traction in recent years due to its critical role in the accurate detection and management of viral infections. Known for their precision, speed, and ability to identify genetic material of viruses, molecular diagnostic tests are widely used across healthcare facilities, research laboratories, and point-of-care settings. These diagnostics provide effective solutions for early disease detection, monitoring of treatment efficacy, and outbreak control, ensuring

All 5 Releases


More Releases for Atrophic

Atrophic Vaginitis Market Will Reach USD 3.9 Billion by 2034
The atrophic vaginitis market is projected to grow from USD 2.1 billion in 2024 to USD 3.9 billion by 2034, at a CAGR of 6.3%, driven by heightened focus on women's health and the introduction of targeted, personalized therapies. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70724 Market Overview • 2024 Market Size: USD 2.1 billion • 2034 Forecast: USD 3.9 billion • CAGR (2024-2034): 6.3% • Key Growth Drivers: Aging population, postmenopausal health awareness, telemedicine adoption, and
Atrophic Scar Treatment Market Driven by Rising Aesthetic Concerns and Advanced …
✅ Atrophic Scar Treatment Market: Trends, Insights, and Future Outlook The global Atrophic Scar Treatment Market is evolving rapidly, driven by technological innovations and rising aesthetic consciousness among consumers. Atrophic scars, commonly resulting from acne, chickenpox, or surgical procedures, often require long-term treatment solutions such as laser therapy, chemical peels, and dermal fillers. In 2025, the market is expected to reach a value of US$ 7.9 Bn, and by 2032, it
Atrophic Glossitis Treatment Market Trends, Demand, and Future Outlook
Atrophic Glossitis Treatment market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Atrophic Glossitis Treatment Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply
Swine Atrophic Rhinitis Vaccine Market- Size, Share, Analysis, and Trends, 2020- …
Dhirtek Business Research and Consulting recently released their most comprehensive study on the global swine atrophic rhinitis vaccine market. This research report provides a detailed overview of the market's drivers and restraints, as well as a thorough analysis of the current trends that are likely to shape its future. To create this in-depth report, the team of analysts used both primary and secondary research methods. The report offers an unbiased
Atrophic Scar Treatment Market Outlook (2019-2025) | Smith & Nephew, Merz, CCA I …
The Global Atrophic Scar Treatment market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Atrophic Scar Treatment Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of
Atrophic Gastritis Global Clinical Trials Review, H1, 2017
"The Report Atrophic Gastritis Global Clinical Trials Review, H1, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Atrophic Gastritis Clinical Trials Market Summary GlobalData's clinical trial report, Atrophic Gastritis Global Clinical Trials Review, H1, 2017" provides an overview of Atrophic Gastritis clinical trials scenario. This report provides top line data relating to the clinical trials on Atrophic Gastritis. Report includes an